INTRODUCTION
 140 genital samples collected in two laboratories from unique patients in Bern during 2014.
 ID and AST were obtained using the mycoplasma IST 2 kit (bioMérieux) and sequencing of 16S rDNA.
 Serovars were obtained with a PCR-based method (Kong et al., J Clin Microbiol, 2000) and clonality was analyzed with MLST and expanded MLST (eMLST) as described previously (Zhang et al., Eur J Clin Microbiol Infect Dis, 2014; Zhang et al., Plos One, 2014) .
 Quinolone and macrolide resistance were studied by sequencing gyrA/B, parC/E, as well as genes encoding 23S rRNA and L4/22 ribosomal proteins.
 Phylogenetic analysis of the detected sequence types (STs) was performed using the concatenated sequences of the four MLST housekeeping genes with MEGA 5.0 software implementing the neighbor-joining method with bootstrap tests (1,000 replicates).
MATERIALS AND METHODS
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 Ureaplasma urealyticum, Ureaplasma parvum, and Mycoplasma hominis are causative agents of urogenital tract infections such as non-chlamydial and non-gonococcal urethritis, prostatitis, cervicitis, and pelvic inflammatory disease.
 Antibiotic resistance in U. urealyticum, U. parvum and M. hominis (MH) poses an increasing issue. However, data regarding antibiotic susceptibility is limited to several countries, whereas information about clonality is available only from China (Zhang et al., Eur J Clin Microbiol Infect Dis, 2014) .
 To our knowledge, data on the antimicrobial susceptibility of genital mycoplasmas isolated in Switzerland are completely lacking. More importantly, information concerning the spread of specific clones at the international level is urgently needed. Therefore, the aim of this study was to fill these gaps by analyzing the Ureaplasma isolates detected among Swiss people.
CONCLUSIONS:
RESULTS: Clonal distribution, subtypes, antibiotic phenotypes and molecular characterization of 25 Ureaplasma isolates  The main Chinese clones were present: ST4 was the most prevalent among UPA isolates, but ST1, ST2, ST22, ST38, and ST58 were also detected. With regard to UUA, unique ST9, ST47, and ST54 were identified.
 Only 5 of 15 CIP-nonsusceptible isolates (based on the IST 2 kit) had mutations in the QRDRs. This previously observed phenomenon was ascribed to mechanisms not yet recognized; however, the IST 2 kit might overrate the FQ resistance (high MICs that are actually in the susceptible range with the microdilution method).
 In the QRDR, only the well-described Ser83Leu substitution in ParC conferred resistance to CIP, whereas both Thr417Val (for UUA) and Val417Thr (for UPA) ParE substitutions did not significantly influence the MICs.
 None of the four isolates nonsusceptible to macrolides possessed substitutions in L4, L22 or the 23S rRNA copies. This may be explained by the fact that: (i) our four isolates were actually susceptible to macrolides according to the CLSI criteria, and (ii) all macrolide-nonsusceptible strains were truly sensitive when tested with the microdilution method.
The phylogenetic analysis performed on 6 UUA and 11 UPA isolates indicated that most of the novel STs found are strongly related to the ancestors (ST1 for UPA and ST47 for UUA) and to the very prevalent Chinese variants (ST1, ST2, ST4, ST22, and ST9).
 This is the first study analyzing susceptibility of Ureaplasma spp. isolates detected in Switzerland and the clonal distribution outside China.
 Resistance rates are low compared to other surrounding countries, but the empirical use of quinolones is compromised.
 Conflicting results from the IST 2 kit and standard broth microdilution were observed for CIP and AZI (i.e., most of the isolates routinely reported as nonsusceptible to these antibiotics were actually fully sensitive)
 We hypothesize that some hyperepidemic STs (e.g., ST4) spread worldwide via sexual intercourse.
 Unfortunately, our study does not provide adequate clinical data to establish the extent of infection or colonization and the potential link with specific STs of U. urealyticum and U. parvum among our patients: Large combined microbiological and clinical studies should address these important aspects in the near future. 
